EVOLENT HEALTH INC - A (EVH) Stock Fundamental Analysis
NYSE:EVH - New York Stock Exchange, Inc. - US30050B1017 - Common Stock - Currency: USD
EVH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. EVH has a bad profitability rating. Also its financial health evaluation is rather negative. EVH has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
EVH had positive earnings in the past year.
EVH had a positive operating cash flow in the past year.
In the past 5 years EVH always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: EVH reported negative operating cash flow in multiple years.
1.2 Ratios
EVH has a Return On Assets of -5.29%. This is in the better half of the industry: EVH outperforms 77.14% of its industry peers.
EVH's Return On Equity of -12.45% is fine compared to the rest of the industry. EVH outperforms 71.43% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.85%, EVH is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.29% | ||
| ROE | -12.45% | ||
| ROIC | 0.85% |
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
EVH has a Operating Margin of 0.93%. This is in the better half of the industry: EVH outperforms 68.57% of its industry peers.
Looking at the Gross Margin, with a value of 15.25%, EVH is doing worse than 80.00% of the companies in the same industry.
In the last couple of years the Gross Margin of EVH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.93% | ||
| PM (TTM) | N/A | ||
| GM | 15.25% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
2. Health
2.1 Basic Checks
EVH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for EVH has been increased compared to 1 year ago.
EVH has more shares outstanding than it did 5 years ago.
EVH has a worse debt/assets ratio than last year.
2.2 Solvency
EVH has an Altman-Z score of 0.92. This is a bad value and indicates that EVH is not financially healthy and even has some risk of bankruptcy.
EVH has a Altman-Z score (0.92) which is in line with its industry peers.
EVH has a Debt/Equity ratio of 0.73. This is a neutral value indicating EVH is somewhat dependend on debt financing.
The Debt to Equity ratio of EVH (0.73) is worse than 74.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.92 |
ROIC/WACC0.09
WACC9.12%
2.3 Liquidity
EVH has a Current Ratio of 0.98. This is a bad value and indicates that EVH is not financially healthy enough and could expect problems in meeting its short term obligations.
EVH has a worse Current ratio (0.98) than 74.29% of its industry peers.
A Quick Ratio of 0.98 indicates that EVH may have some problems paying its short term obligations.
EVH has a Quick ratio of 0.98. This is in the lower half of the industry: EVH underperforms 74.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
EVH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -62.38%.
The Earnings Per Share has been growing by 220.75% on average over the past years. This is a very strong growth
The Revenue has grown by 10.25% in the past year. This is quite good.
EVH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.04% yearly.
EPS 1Y (TTM)-62.38%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%-82.35%
Revenue 1Y (TTM)10.25%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-24.39%
3.2 Future
EVH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.58% yearly.
The Revenue is expected to grow by 7.73% on average over the next years.
EPS Next Y-45.99%
EPS Next 2Y-4.83%
EPS Next 3Y7.03%
EPS Next 5Y11.58%
Revenue Next Year-19.73%
Revenue Next 2Y-3.44%
Revenue Next 3Y2.08%
Revenue Next 5Y7.73%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 24.76, EVH is valued on the expensive side.
Based on the Price/Earnings ratio, EVH is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.91. EVH is around the same levels.
EVH is valuated correctly with a Price/Forward Earnings ratio of 15.74.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EVH indicates a rather cheap valuation: EVH is cheaper than 85.71% of the companies listed in the same industry.
EVH is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.11, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.76 | ||
| Fwd PE | 15.74 |
4.2 Price Multiples
EVH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EVH is cheaper than 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 11.13 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.83%
EPS Next 3Y7.03%
5. Dividend
5.1 Amount
No dividends for EVH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
9.41
-0.24 (-2.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners109.33%
Inst Owner Change-0.29%
Ins Owners1.23%
Ins Owner Change6.89%
Market Cap1.10B
Analysts83.33
Price Target18.06 (91.92%)
Short Float %15.19%
Short Ratio6.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-185.37%
Min EPS beat(2)-332.96%
Max EPS beat(2)-37.77%
EPS beat(4)1
Avg EPS beat(4)-110.42%
Min EPS beat(4)-332.96%
Max EPS beat(4)17.44%
EPS beat(8)5
Avg EPS beat(8)0.86%
EPS beat(12)8
Avg EPS beat(12)38.86%
EPS beat(16)12
Avg EPS beat(16)463.28%
Revenue beat(2)1
Avg Revenue beat(2)1.17%
Min Revenue beat(2)-1.7%
Max Revenue beat(2)4.03%
Revenue beat(4)2
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-1.9%
Max Revenue beat(4)4.03%
Revenue beat(8)5
Avg Revenue beat(8)1.03%
Revenue beat(12)7
Avg Revenue beat(12)0.95%
Revenue beat(16)10
Avg Revenue beat(16)1.14%
PT rev (1m)0%
PT rev (3m)-0.86%
EPS NQ rev (1m)-3.29%
EPS NQ rev (3m)-25.33%
EPS NY rev (1m)0.52%
EPS NY rev (3m)-24.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.76 | ||
| Fwd PE | 15.74 | ||
| P/S | 0.46 | ||
| P/FCF | N/A | ||
| P/OCF | 59.97 | ||
| P/B | 0.98 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.13 |
EPS(TTM)0.38
EY4.04%
EPS(NY)0.6
Fwd EY6.35%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.16
OCFY1.67%
SpS20.43
BVpS9.61
TBVpS-5.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.29% | ||
| ROE | -12.45% | ||
| ROCE | 1.17% | ||
| ROIC | 0.85% | ||
| ROICexc | 0.96% | ||
| ROICexgc | 51.32% | ||
| OM | 0.93% | ||
| PM (TTM) | N/A | ||
| GM | 15.25% | ||
| FCFM | N/A |
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
F-Score5
Asset Turnover0.9
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.06 | ||
| Cap/Depr | 24.92% | ||
| Cap/Sales | 1.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 13.62% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 0.92 |
F-Score5
WACC9.12%
ROIC/WACC0.09
Cap/Depr(3y)38.35%
Cap/Depr(5y)41.66%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-62.38%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%-82.35%
EPS Next Y-45.99%
EPS Next 2Y-4.83%
EPS Next 3Y7.03%
EPS Next 5Y11.58%
Revenue 1Y (TTM)10.25%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-24.39%
Revenue Next Year-19.73%
Revenue Next 2Y-3.44%
Revenue Next 3Y2.08%
Revenue Next 5Y7.73%
EBIT growth 1Y3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year301.67%
EBIT Next 3Y83.07%
EBIT Next 5Y54.61%
FCF growth 1Y4.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.42%
OCF growth 3Y-21.47%
OCF growth 5YN/A